Every year your child's prescription increases, their eye physically grows longer.
That's not just stronger glasses — it's structural damage that accumulates silently, raising the risk of retinal detachment, macular degeneration, and early blindness.
12.2% of children with −6.00D develop macular damage within 4 years
That's not a distant adult risk. It's happening to children aged 7–17 in Singapore right now. The earlier progression is caught, the more of your child's vision can be protected.
Where is your child heading by age 18?
A child diagnosed at age 8 with −1.00D, progressing at −0.75D/year without any intervention, reaches −7.50D by age 18 — deep into the high-risk zone for all four conditions below.
At −0.75D/yr progression · No myopia control treatment
What high myopia leads to
Each risk is documented in peer-reviewed research. Tap any card to see the source.
The treatment window closes with age
Myopia control — MiSight, Stellest, ortho-k, low-dose atropine — works best when started early. Every year of unchecked progression narrows the window.
Based on IMI 2025 myopia control efficacy data
Know where your child's prescription is heading — before it's too late to act
The Velocity Report projects your child's trajectory to age 18 across six treatment scenarios, grounded in SCORM and IMI 2025 clinical data. Developed by an OOB-registered optometrist.
10 spots only · Rate locked permanently · Full refund after 30 days if not useful
All statistics are drawn from peer-reviewed publications. Educational purposes only — not medical advice. Always consult a registered eye care professional. Developed by an OOB-registered optometrist. Photo by Ivan Aleksic via Unsplash.